LIFECORE BIOMEDICAL, INC. Long-Term Debt, Maturity, Year Four
LIFECORE BIOMEDICAL, INC. (LFCR) had Long-Term Debt, Maturity, Year Four of $1.07 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour · last filed 2026-08-05
- 2026-06-30: Long-Term Debt, Maturity, Year Four $1.07M.
- 2026-03-31: Long-Term Debt, Maturity, Year Four $1.07M.
- 2025-12-31: Long-Term Debt, Maturity, Year Four $185.14M.
- 2025-09-30: Long-Term Debt, Maturity, Year Four $180.61M.
| Period end | Long-Term Debt, Maturity, Year Four |
|---|---|
| 2026-06-30 | $1.07M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $1.07M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $185.14M 10-KT · filed 2026-03-16 |
| 2025-09-30 | $180.61M 10-Q · filed 2025-11-06 |
| 2025-05-25 | $174.55M 10-K · filed 2025-08-07 |
| 2025-02-23 | $170.32M 10-Q · filed 2025-04-03 |
| 2024-11-24 | $166.05M 10-Q · filed 2025-01-02 |
| 2024-08-25 | $162.02M 10-Q · filed 2024-10-04 |
| 2024-05-26 | $773.00K 10-K · filed 2024-08-26 |
| 2024-02-25 | $773.00K 10-Q · filed 2024-08-09 |
| 2023-11-26 | $773.00K 10-Q · filed 2024-08-09 |
| 2023-08-27 | $773.00K 10-Q · filed 2024-08-09 |
| 2022-05-29 | $84.70M 10-K/A · filed 2023-03-16 |
| 2021-05-30 | $8.42M 10-K · filed 2021-07-29 |
| 2019-05-26 | $77.50M 10-K · filed 2019-08-01 |
| 2018-05-27 | $27.50M 10-K · filed 2018-08-09 |
| 2017-05-28 | $5.00M 10-K/A · filed 2018-03-15 |
| 2016-05-29 | $9.21M 10-K · filed 2016-08-01 |
| 2015-05-31 | $6.00M 10-K · filed 2015-07-31 |
| 2014-05-25 | $3.46M 10-K · filed 2014-08-01 |
| 2013-05-26 | $3.32M 10-K · filed 2013-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |